Status:
COMPLETED
Use of Integrated PET/CT as a First Line Staging and Re-staging Technique in Oncologic Patient.
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Positron emission tomoscintigraphy (PET) and contrast computed tomography (CTmdc) are diagnostic methods widely used in the staging and restaging of neoplastic diseases. In recent years, PET tomograph...
Eligibility Criteria
Inclusion
- patients suffering from lung cancer or lymphoma in which the two diagnostic investigations mentioned (PET and contrast-enhanced CT) are part of the routine diagnostic-therapeutic program of the disease in question;
- Patients suffering from lung cancer will be in the stage of primary neoplasm staging;
- Patients suffering from lymphoma will be evaluated both in the disease staging phase at onset and re-evaluation after radio-chemotherapy treatment.
Exclusion
- Patients with contraindications to performing investigations with contrast medium.
Key Trial Info
Start Date :
October 21 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 3 2014
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06168877
Start Date
October 21 2009
End Date
July 3 2014
Last Update
December 13 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.